1-7 of 7
Alain Rahmouni
Close
Sort by
Journal Articles

Lenalidomide Plus Bortezomib and Dexamethasone (RVD) Followed by Lenalidomide Plus Dexamethasone As Salvage Treatment for Myeloma Patients in First Relapse After Autologous Stem Cell Transplantation. Single Institution Experience

Karim Belhadj, MD, Kamel Amraoui, MD, Violaine Safar, MD, Isabelle Gaillard, MD, Taoufik El Gnaoui, MD, Jehan Dupuis, MD, Alain Luciani, MD, PhD, Valérie Molinier-Frenkel, MD, Alain Rahmouni, MD, PhD, Corinne Haioun
Journal: Blood
Blood (2011) 118 (21): 5143.
https://doi.org/10.1182/blood.V118.21.5143.5143
Published: 2011
Journal Articles

Prognostic Value of Early 18fluorodeoxyglucose PET Scan in Patients with Diffuse Large B Cell Lymphoma Treated with Rituximab Plus CHOP or High-Dose CHOP.

Jehan Dupuis, Emmanuel Itti, Christophe Fruchart, Stéphane Bardet, Alain Rahmouni, Jean-Pierre Vilque, Chieh Lin, Karim Belhadj, Taoufik El Gnaoui, Frédérique Kuhnowski, Michel Meignan, Corinne Haioun
Journal: Blood
Blood (2008) 112 (11): 2006.
https://doi.org/10.1182/blood.V112.11.2006.2006
Published: 2008
Journal Articles

Response Assessment after an Inductive CHOP or CHOP-Like Regimen with or without Rituximab in 103 Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Integrating 18 Fluorodeoxyglucose Positron Emission Tomography (PET) to the International Workshop Criteria (IWC).

Jehan Dupuis, MD, Emmanuel Itti, MD,PhD, Alain Rahmouni, MD,PhD, Jean-Didier Rain, MD,PhD, Christian Gisselbrecht, MD,PhD, Karim Belhadj, MD, Taoufik El Gnaoui, MD, Isabelle Gaillard, MD, Chieh Lin, MD, Nicolas Mounier, MD,PhD, Philippe Gaulard, MD,PhD, Michel Meignan, MD,PhD, Felix Reyes, MD,PhD, Corinne Haioun, MD
Journal: Blood
Blood (2006) 108 (11): 2735.
https://doi.org/10.1182/blood.V108.11.2735.2735
Published: 2006
Journal Articles

Rituximab in Combination with CHOP Regimen in Angioimmunoblastic T-Cell Lymphoma (AITL). Preliminary Results in 9 Patients Treated in a Single Institution.

Bertrand Joly, Valerie Frenkel, Philippe Gaulard, Karim Belhadj, Taoufik El Gnaoui, Jehan Dupuis, Marine Divine, Alain Rahmouni, Christiane Copie Bergman, Marie Helene Delfau-Larue, Felix Reyes, Corinne Haioun
Journal: Blood
Blood (2005) 106 (11): 2686.
https://doi.org/10.1182/blood.V106.11.2686.2686
Published: 2005
Journal Articles

Early Response Evaluation with 18 FDG-PET Scanning, but Not Phenotypic Profile, Are Predictive of Outcome in Diffuse Large B-Cell Lymphoma.

Jehan Dupuis, Philippe Gaulard, Emmanuel Itti, Alain Rahmouni, François Hemery, Josette Brière, Bettina Fabiani, Christiane Copie-Bergman, Christian Gisselbrecht, Michel Meignan, Félix Reyes, Corinne Haioun
Journal: Blood
Blood (2005) 106 (11): 1914.
https://doi.org/10.1182/blood.V106.11.1914.1914
Published: 2005
Journal Articles

[ 18 F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

Clinical Trials & Observations
Corinne Haioun, Emmanuel Itti, Alain Rahmouni, Pauline Brice, Jean-Didier Rain, Karim Belhadj, Philippe Gaulard, Laurent Garderet, Eric Lepage, Felix Reyes, Michel Meignan
Journal: Blood
Blood (2005) 106 (4): 1376–1381.
https://doi.org/10.1182/blood-2005-01-0272
Published: 2005
Journal Articles

Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX): A Promising Regimen for Refractory/Relapsed B-Cell Lymphoma.

Taoufik El Gnaoui, Jehan Dupuis, Bertrand Joly, Karim Belhadj, Alain Rahmouni, Christiane Copie-Bergman, Antoine Allain, Isabelle Tabah-Fish, Felix Reyes, Corinne Haioun
Journal: Blood
Blood (2004) 104 (11): 2483.
https://doi.org/10.1182/blood.V104.11.2483.2483
Published: 2004